Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia.

MLA

Albinger, Nawid, et al. “Primary CD33-Targeting CAR-NK Cells for the Treatment of Acute Myeloid Leukemia.” Blood Cancer Journal, vol. 12, no. 4, Apr. 2022, p. 61. EBSCOhost, https://doi.org/10.1038/s41408-022-00660-2.

APA

Albinger, N., Pfeifer, R., Nitsche, M., Mertlitz, S., Campe, J., Stein, K., Kreyenberg, H., Schubert, R., Quadflieg, M., Schneider, D., Kühn, M. W. M., Penack, O., Zhang, C., Möker, N., & Ullrich, E. (2022). Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia. Blood Cancer Journal, 12(4), 61. https://doi.org/10.1038/s41408-022-00660-2

Chicago

Albinger, Nawid, Rita Pfeifer, Marcus Nitsche, Sarah Mertlitz, Julia Campe, Katja Stein, Hermann Kreyenberg, et al. 2022. “Primary CD33-Targeting CAR-NK Cells for the Treatment of Acute Myeloid Leukemia.” Blood Cancer Journal 12 (4): 61. doi:10.1038/s41408-022-00660-2.